Cargando…
Challenges and opportunities for improving access to approved neonatal drugs and devices
Neonatal drug and device development has lagged behind other patient populations. Oftentimes, providers are using drugs and devices without adequate study of safety and efficacy. Neonates deserve dedicated drug and device development programs, which will require novel approaches and unique collabora...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819193/ https://www.ncbi.nlm.nih.gov/pubmed/35132149 http://dx.doi.org/10.1038/s41372-021-01304-2 |